skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 53  for All Library Resources

Results 1 2 3 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
Material Type:
Article
Add to My Research

The efficacy and safety of aflibercept and conbercept in diabetic macular edema

Drug design, development and therapy, 2018-01, Vol.12, p.3471-3483 [Peer Reviewed Journal]

2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Cai et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S177192 ;PMID: 30410308

Full text available

2
The Effect of Anti-Vascular Endothelial Growth Factor on Retinal Microvascular Changes in Diabetic Macular Edema Using Swept-Source Optical Coherence Tomography Angiography
Material Type:
Article
Add to My Research

The Effect of Anti-Vascular Endothelial Growth Factor on Retinal Microvascular Changes in Diabetic Macular Edema Using Swept-Source Optical Coherence Tomography Angiography

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.3871-3880 [Peer Reviewed Journal]

2020 Pongsachareonnont et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Pongsachareonnont et al. 2020 Pongsachareonnont et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s270410 ;PMID: 33235428

Full text available

3
Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
Material Type:
Article
Add to My Research

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.603-609 [Peer Reviewed Journal]

2022 Tran et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;Distributed under a Creative Commons Attribution 4.0 International License ;2022 Tran et al. 2022 Tran et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S352152 ;PMID: 35310546

Full text available

4
Optical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular Edema
Material Type:
Article
Add to My Research

Optical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular Edema

Diabetes, metabolic syndrome and obesity, 2022-01, Vol.15, p.395-405 [Peer Reviewed Journal]

2022 Elnahry et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Elnahry et al. 2022 Elnahry et al. ;ISSN: 1178-7007 ;EISSN: 1178-7007 ;DOI: 10.2147/DMSO.S351618 ;PMID: 35177916

Full text available

5
Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory Therapies
Material Type:
Article
Add to My Research

Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory Therapies

Drug design, development and therapy, 2022-03, Vol.16, p.717-725 [Peer Reviewed Journal]

2022 Ding et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Ding et al. 2022 Ding et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S351683 ;PMID: 35313554

Full text available

6
Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options
Material Type:
Article
Add to My Research

Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.375-385 [Peer Reviewed Journal]

2021 Veritti et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Veritti et al. 2021 Veritti et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S236423 ;PMID: 33551641

Full text available

7
Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
Material Type:
Article
Add to My Research

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.1103-1110 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Dugel et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S100764 ;PMID: 27366049

Full text available

8
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
Material Type:
Article
Add to My Research

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema

Clinical interventions in aging, 2013-01, Vol.8, p.467-483 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Fong and Lai, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S36811 ;PMID: 23766636

Full text available

9
Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?
Material Type:
Article
Add to My Research

Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?

Clinical ophthalmology (Auckland, N.Z.), 2022-07, Vol.16, p.2275-2283 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Asami et al. 2022 Asami et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S356727 ;PMID: 35872969

Full text available

10
Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review
Material Type:
Article
Add to My Research

Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.3709-3720 [Peer Reviewed Journal]

2021 Muste et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Muste et al. 2021 Muste et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S272327 ;PMID: 34511875

Full text available

11
Vitrectomy for center-involved diabetic macular edema
Material Type:
Article
Add to My Research

Vitrectomy for center-involved diabetic macular edema

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.735-742 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Browning et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s104906 ;PMID: 27175056

Full text available

12
Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?
Material Type:
Article
Add to My Research

Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?

Drug design, development and therapy, 2024-01, Vol.18, p.365-374 [Peer Reviewed Journal]

2024 Chatzimichail et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;2024 Chatzimichail et al. 2024 Chatzimichail et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S457303 ;PMID: 38347957

Full text available

13
Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes
Material Type:
Article
Add to My Research

Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.579-592 [Peer Reviewed Journal]

2022 Shimura et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Shimura et al. 2022 Shimura et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S344194 ;PMID: 35256840

Full text available

14
Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019
Material Type:
Article
Add to My Research

Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019

Clinical pharmacology: advances and applications, 2022-01, Vol.14, p.37-47 [Peer Reviewed Journal]

2022 Ahmedalgabri et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Ahmedalgabri et al. 2022 Ahmedalgabri et al. ;ISSN: 1179-1438 ;EISSN: 1179-1438 ;DOI: 10.2147/CPAA.S338926 ;PMID: 35411193

Full text available

15
One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
Material Type:
Article
Add to My Research

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.1971-1978 [Peer Reviewed Journal]

2021 Tran et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Tran et al. 2021 Tran et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S304030 ;PMID: 34007150

Full text available

16
Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
Material Type:
Article
Add to My Research

Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients

Clinical ophthalmology (Auckland, N.Z.), 2018-01, Vol.12, p.13-20 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Ehlken et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S151611 ;PMID: 29339917

Full text available

17
Optical Coherence Tomographic Patterns as Predictors of Structural Outcome After Intravitreal Ranibizumab in Diabetic Macula Edema
Material Type:
Article
Add to My Research

Optical Coherence Tomographic Patterns as Predictors of Structural Outcome After Intravitreal Ranibizumab in Diabetic Macula Edema

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.4023-4030 [Peer Reviewed Journal]

2020 Chen et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Chen et al. 2020 Chen et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S264669 ;PMID: 33262567

Full text available

18
Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex ® Outcomes
Material Type:
Article
Add to My Research

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex ® Outcomes

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.4153-4162 [Peer Reviewed Journal]

2021 Udaondo et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Udaondo et al. 2021 Udaondo et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S336865 ;PMID: 34703201

Full text available

19
Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
Material Type:
Article
Add to My Research

Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.921-929 [Peer Reviewed Journal]

2020 Abu-Yaghi et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Abu-Yaghi et al. 2020 Abu-Yaghi et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S248661 ;PMID: 32273676

Full text available

20
Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
Material Type:
Article
Add to My Research

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.4097-4108 [Peer Reviewed Journal]

2021 Wei et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Wei et al. 2021 Wei et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S325618 ;PMID: 34675477

Full text available

Results 1 - 20 of 53  for All Library Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait